在非小细胞肺癌中,遗传突变和器官转移之间的关系
Haiying Xue1, Yuzhu Chen2,3, Fei Qi2,3
1School of Medicine, Sun Yat-sen University, Shenzhen, China.
Therapeutic advances in medical oncology
|February 26, 2026
概括
非小细胞肺癌 (NSCLC) 的遗传突变显著影响转移模式. 了解这些基因突变可以帮助预测转移部位,并个性化治疗策略,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 非小细胞肺癌 (NSCLC) 是全球癌症死亡的主要原因.
- 在NSCLC中,高转移潜力导致预后不佳.
- 分子测试揭示了影响NSCLC进展的关键驱动和非驱动基因.
研究的目的:
- 审查NSCLC中特定基因突变和转移部位之间的联系.
- 探索驱动NSCLC转移的分子机制.
- 讨论基因分析对风险预测和个性化治疗的潜力.
主要方法:
- 关于NSCLC遗传学和转移的研究的文献综述.
- 对基因突变 (EGFR,ALK,KRAS,TP53,STK11,KEAP1) 和转移模式之间的关联进行分析.
- 探索潜在的分子通路.
主要成果:
- EGFR和ALK突变与大脑转移有关.
- KRAS突变与骨,肝脏和肺部转移相关.
- TP53,STK11和KEAP1突变增加了多器官转移的风险.
结论:
- 遗传突变在确定NSCLC转移行为的过程中起着至关重要的作用.
- 基于突变的风险预测可以指导转移预防和早期干预.
- 根据基因分析的个人化治疗策略,有望优化NSCLC治疗.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
15.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.1K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Cancer
55.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.0K
Cancer Prevention
8.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.3K
Tumor Progression
7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K
Mutations
95.0K
Overview
95.0K


